These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16286588)

  • 1. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.
    Sales VL; Sukhova GK; Lopez-Ilasaca MA; Libby P; Dzau VJ; Pratt RE
    Circulation; 2005 Nov; 112(21):3328-36. PubMed ID: 16286588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque.
    Dandapat A; Hu CP; Chen J; Liu Y; Khan JA; Remeo F; Carey RM; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2008 Feb; 366(4):871-7. PubMed ID: 18037370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S
    J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
    Daugherty A; Rateri DL; Lu H; Inagami T; Cassis LA
    Circulation; 2004 Dec; 110(25):3849-57. PubMed ID: 15596561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ; Chan L
    Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
    Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
    Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis in mice is not affected by a reduction in tissue factor expression.
    Tilley RE; Pedersen B; Pawlinski R; Sato Y; Erlich JH; Shen Y; Day S; Huang Y; Eitzman DT; Boisvert WA; Curtiss LK; Fay WP; Mackman N
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):555-62. PubMed ID: 16385085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA
    Circulation; 2009 Apr; 119(16):2188-95. PubMed ID: 19380618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
    Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions.
    Kato T; Kawahito H; Kishida S; Irie D; Wakana N; Kikai M; Takata H; Ogata T; Ueyama T; Matoba S; Yamada H
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):936-46. PubMed ID: 25487979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice.
    Kuzuya M; Nakamura K; Sasaki T; Cheng XW; Itohara S; Iguchi A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1120-5. PubMed ID: 16556856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques.
    Zulli A; Burrell LM; Widdop RE; Black MJ; Buxton BF; Hare DL
    J Histochem Cytochem; 2006 Feb; 54(2):147-50. PubMed ID: 16116029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
    Isoda K; Sawada S; Ishigami N; Matsuki T; Miyazaki K; Kusuhara M; Iwakura Y; Ohsuzu F
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1068-73. PubMed ID: 15059807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.